David Leo Fischel is Chairman and CEO of Stereotaxis, a global leader in robotic technologies for cardiac arrhythmia ablation and catheter navigation. He also serves as a Principal at DAFNA Capital Management, bringing over two decades of experience in life sciences investment. A CPA, CFA, and CAIA charterholder, he holds an MBA from Bar-Ilan University and has extensive expertise at the intersection of healthcare, technology, and finance.